MYDA Advisors’s Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share CLAA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-40,000
Closed -$16K 263
2022
Q1
$16K Hold
40,000
0.01% 196
2021
Q4
$29K Hold
40,000
0.01% 242
2021
Q3
$32K Hold
40,000
0.01% 253
2021
Q2
$43K Buy
+40,000
New +$36.8K 0.01% 269

Other funds holding CLAA.WS

MYDA Advisors's CLAA.WS Position: Q2 2022 in Review

MYDA Advisors sold out of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) in Q2 2022, closing a stake of 40,000 shares — an estimated $16K sold.

MYDA Advisors first reported a position in CLAA.WS in Q2 2021 and held it in 4 quarters. The position peaked at $43K in Q2 2021. 42 funds tracked by Wall St. Rank hold CLAA.WS as of Q2 2022.

  • MYDA Advisors reported no remaining Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • MYDA Advisors sold 40,000 Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q2 2022, an estimated $16K.
  • MYDA Advisors first reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 4 quarters.
  • MYDA Advisors's Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $43K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q2 2022.

Based on MYDA Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.